The calcium-sensing receptor promotes urinary acidification to prevent nephrolithiasis. by Renkema, K.Y. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/81328
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
The Calcium-Sensing Receptor Promotes Urinary
Acidification to Prevent Nephrolithiasis
Kirsten Y. Renkema,* Ana Velic,† Henry B. Dijkman,‡ Sjoerd Verkaart,*
Annemiete W. van der Kemp,* Marta Nowik,† Kim Timmermans,* Alain Doucet,§
Carsten A. Wagner,† Rene´ J. Bindels,* and Joost G. Hoenderop*
*Department of Physiology, Nijmegen Centre for Molecular Life Sciences, and ‡Department of Pathology, Radboud
University Nijmegen Medical Centre, Nijmegen, Netherlands; †Institute of Physiology and Zu¨rich Center for
Integrative Human Physiology, University of Zurich, Zurich, Switzerland; and §Laboratoire de Physiologie et
Ge´nomique Re´nales, CNRS/UPMC UMR 7134, Institut des Cordeliers, Paris, France
ABSTRACT
Hypercalciuria increases the risk for urolithiasis, but renal adaptive mechanisms reduce this risk. For example,
transient receptor potential vanilloid 5 knockout (TPRV5/) mice lack kidney stones despite urinary calcium
(Ca2) wasting and hyperphosphaturia, perhaps as a result of their significant polyuria and urinary acidifica-
tion. Here, we investigated themechanisms linking hypercalciuria with these adaptive mechanisms. Exposure
of dissected mouse outer medullary collecting ducts to high (5.0 mM) extracellular Ca2 stimulated H-
ATPase activity. In TRPV5/ mice, activation of the renal Ca2-sensing receptor promoted H-ATPase–
mediated H excretion and downregulation of aquaporin 2, leading to urinary acidification and polyuria,
respectively. Gene ablation of the collecting duct-specific B1 subunit of H-ATPase in TRPV5/ mice
abolished the enhanced urinary acidification, which resulted in severe tubular precipitations of Ca2-phos-
phate in the renal medulla. In conclusion, activation of Ca2-sensing receptor by increased luminal Ca2 leads
to urinary acidification and polyuria. These beneficial adaptations facilitate the excretion of large amounts of
soluble Ca2, which is crucial to prevent the formation of kidney stones.
J Am Soc Nephrol 20: 1705–1713, 2009. doi: 10.1681/ASN.2008111195
Hypercalciuria constitutes the main risk factor in
urolithiasis. Patients with renal stone disease expe-
rience severe pain, a high rate of recurrence, slowly
progressing tissue damage, and eventually renal in-
sufficiency, and recurrent clinical treatment is
needed.1,2 Different types of hypercalciuria are
known. In this respect, absorptive, renal, and re-
sorptive hypercalciuria are distinguished: Dis-
turbed intestinal Ca2 hyperabsorption, impaired
renal Ca2 reabsorption, and increased bone re-
sorption, respectively, are primarily involved.3–6
Current treatment strategies of renal stones con-
sist of (pain) medication, dietary adjustments,
hydration, extracorporeal shock wave treatment,
or surgery.
The transient receptor potential vanilloid mem-
ber 5 (TRPV5), the epithelial Ca2 channel, which
is expressed in the renal distal convoluted tubule
(DCT) and the connecting tubule (CNT), consti-
tutes the major apical entry step of Ca2 from the
pro-urine into the renal cells.7 TRPV5 knockout
(TRPV5/) mice demonstrate a robust hypercal-
ciuria with hyperphosphaturia, predisposing these
mice to an increased risk for renal Ca2-phosphate
stone formation.8 Concomitantly, TRPV5/mice
display profound polyuria and increased urinary
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acidification.8 Urinary acidification occurs along different seg-
ments of the nephron and is of crucial importance in acid/base
homeostasis.9,10
In combination with urinary buffers, the activity of acid/
base transporters in intercalated cells (ICs) of CNT and collect-
ing duct system (CD) accomplish the fine-tuning of urinary
pH. In type A ICs, the multisubunit vacuolar ATP-driven pro-
ton pump (H-ATPase) is expressed at the apical membrane,
which is mainly responsible for proton excretion.11 Inactivat-
ingmutations in the genes encoding individual subunits of the
H-ATPase proton pump are associated with distal renal tu-
bular acidosis, characterized by a decrease in net proton secre-
tion.12–14 The formation of less acidic urine predisposes to uro-
lithiasis as the crystallization of Ca2-phosphate occurs via the
conversion of phosphate to its divalent form (HPO4
2) in an
alkaline rather than in an acidic environment.15,16 Previously,
insufficient urinary acidification was demonstrated in recur-
rent stone formers.17,18 Currently, no clinical trials have docu-
mented the description of the prevention of stone formation
by stimulating urinary acidification.
Aquaporin 2 (AQP2) is the water channel localized at the
apical membrane of the CNT and CD that is responsible for
vasopressin-regulated urinary water reabsorption.19,20 Previ-
ous studies linked Ca2 and water homeostasis, suggesting a
functional role for the G-protein–coupled Ca2/polyvalent
cation-sensing receptor (CaSR).21–23 Immunolocalization
studies of renal CaSR in rats revealed expression on the apical
membrane of both proximal tubule and CD, the basolateral
membrane of thick ascending limb of Henle (TAL), and a dif-
Figure 1. Urinary Ca2 excretion, volume, and pH. (A and B)
Correlation of urinary Ca2 excretion with (A) urinary volume and (B)
urinary pH in control and TRPV5/mice. Each dot represents single
mouse datum. Linear regression analysis confirmed significant cor-
relations of urinary Ca2 excretion with urinary volume (r2  0.83;
P 0.0001; n 62) and urinary pH (r2  0.70; P 0.0001; n 42).
(C) Urinary Ca2 excretion was determined in 24-h urine samples
of 5-wk-old control, TRPV5/, TRPV5//Atp6v1b1/, and
Atp6v1b1/ mice. TRPV5/ and TRPV5//Atp6v1b1/ mice
showed a significant hypercalciuria, whereas hypocalciuria was
present in Atp6v1b1/ mice compared with control mice. (D)
TRPV5/ mice demonstrated a significant decrease in urinary pH
compared with control mice, whereas TRPV5//Atp6v1b1/mice
exhibited urinary pH levels similar to controls. Impaired urinary acid-
ification in Atp6v1b1/ mice resulted in an increase of urinary pH.
(E) An increased urinary volume was demonstrated in TRPV5/
compared with control mice. TRPV5//Atp6v1b1/ mice dis-
played a further increase in 24-h urinary volume compared with
TRPV5/ mice. In C through E, data are means  SEM. *P  0.05
(n  6; significant difference from control); #P  0.05 (n  6; signif-
icant difference from TRPV5/ mice).
Table 1. Physiologic parameters of control and TRPV5/
micea
Parameter Control TRPV5/
Urine
Ca2 (mol/24 h) 10  2 132  31b
phosphate (mol/24 h) 65  8 142  13b
citrate (mg/24 h) 40  10 56  13
oxalate (mol/24 h) 3.4  0.9 2.7  0.5
volume (ml/24 h) 1.5  0.3 3.6  0.5b
pH 7.4  0.1 5.5  0.1b
osmolality (mOsmol/kg) 1928  201 1222  175b
Serum
Ca2 (mM) 2.36  0.02 2.42  0.02
ionized Ca2 (mM) 1.27  0.01 1.30  0.01
phosphate (mM) 2.5  0.2 2.3  0.1
aUrine and serum biochemical parameters of 8-wk-old control and TRPV5/
mice. Data are means  SEM (n  5).
bP  0.05, significant difference from control mice.
Table 2. Urinary TA in control and TRPV5/ micea
Parameter Control TRPV5/
NH3/NH4
 (mmol/24 h) 0.033  0.006 0.036  0.007
TA (mEq/24 h) 0.048  0.007 0.121  0.006b
HCO3
 (mmol/24 h) 0.002  0.001 0.001  0.001
NAE (mEq/24 h) 0.083  0.012 0.157  0.012b
pH 6.2  0.1 5.6  0.1b
aUrinary TA in a novel experiment with 8-wk-old control and TRPV5/ mice
(n  7). Data are means  SEM.
bP  0.001, significant difference from control mice.
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fuse pattern throughout the DCT.24 Renal CaSR ex-
pression is highest in TAL cells and is absent from the
glomerulus. The differential expression and localiza-
tion of CaSR along the nephron is indicative of the
variety of physiologic functions throughout the kid-
ney. The localization of the CaSR along the CD facil-
itates the activation of the receptor during a hyper-
calciuric state.24 In the CD, a CaSR-mediated
decrease of the urine concentrating ability could
eventually lead to polyuria, assisting the excretion of
large amounts of Ca2.23
The aim of this study was to elucidate molecular
mechanisms involved in the adaptations that prevent
renal stone formation during hypercalciuria. The
TRPV5/ mouse model was used because polyuria
and increased urinary acidification naturally occur in
these hypercalciuric mice. The crucial roles of the func-
tionalH-ATPase proton pump, theAQP2water chan-
nel, and the CaSR are demonstrated in these hypercal-
ciuria-related adaptations. This study provides new
insights regarding the formation and prevention of kid-
ney stones.
RESULTS
Metabolic Studies
At 8-wk-old TRPV5/ and littermate control mice
were housed in metabolic cages for 24 h and killed. Ge-
netic ablation of TRPV5 resulted in hypercalciuria, and
these mice remained normocalcemic (Table 1). In ad-
dition, TRPV5/ mice displayed hyperphosphaturia
with normal serum phosphate levels and a significant
polyuria with decreased urinary osmolality. Urinary ci-
trate and oxalate excretion levels were not different be-
tween the twomouse strains.Urinary pHwas significantly
lower in TRPV5/ mice compared with control mice.
The 24-h ammonium and HCO3
 excretion levels were
unchanged (Table 2). Furthermore, urinary titratable
acidity (TA) was significantly increased in TRPV5/
mice. Consequently, renal net acid excretion (NAE),
which is the sum of renal ammonium excretion and TA
minus HCO3
 excretion, was elevated in TRPV5/
mice. Ca2 excretion levels correlated linearly with uri-
naryvolumeaswell aspH(Figure1,AandB, respectively).
To address the contribution of H-ATPase activity to the
acidified urine in TRPV5/ mice, we generated
TRPV5//Atp6v1b1/ mice that were genetically ab-
lated for both TRPV5 and the IC-specific B1 subunit of
H-ATPase (Atp6v1b1). Hypercalciuria remained
present in 5-wk-old TRPV5//ATP6v1b1/ mice, al-
though less than inTRPV5/mice (Figure 1C).Urinary pHwas
normalized (Figure 1D) whereas urinary volume was further in-
creased in TRPV5//ATP6v1b1/ mice in comparison with
TRPV5/mice (Figure 1E).
Phenotypic Analysis of the TRPV5//ATP6v1b1/
Mice
TRPV5//Atp6v1b1/ mice were retarded in their growth
directly after birth, comparedwith littermatemice (Figure 2A).
Figure 2. Analysis of TRPV5//Atp6v1b1/ mice. (A) Growth curves
comparing body weights of mouse genotypes, representing a litter con-
taining one TRPV5//Atp6v1b1/ mouse that died at 14 d of age
(dotted line) and four littermates (solid lines). (B) Growth retardation in
TRPV5//Atp6v1b1/ mice, demonstrating 5-wk-old control (left) and
TRPV5//Atp6v1b1/ (right) mice. (C) Mortality rate of TRPV5//
Atp6v1b1/ (solid line; n  10) and littermate (dotted line; n  55) mice.
(D) Kidneys from 5-wk-old control (left) and TRPV5//Atp6v1b1/ mice
(right). (E) Renal histology of a 5-wk-old TRPV5//Atp6v1b1/ mouse.
(F) Von Kossa staining in renal sections of a 1-wk-old TRPV5//
Atp6v1b1/ mouse. (G) Transmission electron microscopy image of a
tubular precipitate in the medullary collecting duct of a 1-wk-old TRPV5//
Atp6v1b1/ mouse. (H) STEM image of (1) a precipitate, x-ray maps
separately depicting (2) Ca2, and (3) phosphorus content. (I) Energy
dispersive x-ray microanalysis of the renal precipitate (arrow in H) dem-
onstrating Ca2 and phosphorus content. This spectrum represents all
spot measurements performed (n  35 spots). Magnifications: 100 in E
(left), F (left); 250 in E (right), F (right); 2500 in G.
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At 5 wk of age, TRPV5//Atp6v1b1/ mice were
easily identified because of severe growth retardation
(Figure 2B). Moreover, 80% of the TRPV5//
Atp6v1b1/ mice died within 6 wk after birth (Fig-
ure 2C). These double-knockout mice showed bilat-
eral hydronephrosis (Figure 2D) and abnormal
dilation of the CD (Figure 2E). Von Kossa staining in
kidneys of 1-wk-old TRPV5//Atp6v1b1/ mice
showed massive tubular Ca2 precipitations in the
medullary CD (Figure 2, F and G). Subsequently, kid-
ney samples that included the observed precipitates
were analyzed by energy-dispersive x-ray microanal-
ysis using a Jeol 1200/STEM (Jeol Ltd., Tokyo, Japan)
in combination with a Thermo Noran microanalysis
SIX system (Thermo Fisher Scientific Inc., Waltham,
MA) (Figure 2H). The x-ray maps and spectrum un-
equivocally showed the presence of Ca2 and phos-
phorus (Figure 2, H, 2 and 3, and I) in the precipitates
present in the lumen of the CD suggesting Ca2-
phosphate crystals.
Renal and Intestinal Expression of Water, Acid,
and Phosphate Transporters
To address renal AQP2 expression levels in control and
TRPV5/ mice, we performed immunoblot analyses.
AQP2 was significantly downregulated in TRPV5/
mice compared with control mice at 8 wk of age (Figure
3A). Moreover, a further AQP2 downregulation was
detected in TRPV5//Atp6v1b1/ mice compared
with TRPV5/ mice, analyzed at 5 wk of age (Figure
3B). Membrane fractions were isolated from renal me-
dulla tissue of 8-wk-old TRPV5/ and control mice.
Analysis of AQP2 protein expression in the membrane
fractions revealed a significant downregulation in kid-
neys of TRPV5/ compared with control littermate
mice (Figure 3C). Immunoblotting for the B1 subunit
of H-ATPase revealed no differences in expression
levels between TRPV5/ and control mice (Figure
4A). Furthermore, a significant downregulation of the
renal type IIa NaPi co-transporter (NaPi-IIa) was revealed in
TRPV5/ mice (Figure 4B). In contrast, expression of the
intestinal type IIb NaPi co-transporter (NaPi-IIb) was in-
creased in brush border membrane vesicles isolated from il-
eum of TRPV5/ mice compared with control mice (Figure
4C).
Effect of Ca2 on H-ATPase Activity of Outer
Medullary CDs
We enzymatically isolated outer medullary CDs (OMCDs)
from mouse renal tissue to perform pHi measurements. The
activity of H-ATPase was determined from the pHi recovery
rate (pHi/min) after intracellular acidification by NH4Cl.25
We investigated the effect on H-ATPase activity of low (0.1
mM), normal (1.0 mM), and high (5.0 mM, mimicking the
hypercalciuric state of TRPV5/ mice) extracellular [Ca2].
Representative recordings are depicted in Figure 5, A and C.
Exposure of OMCDs to 5.0mM [Ca2] significantly increased
H-ATPase–mediated pHi recovery rates in control (n 178
cells; 15 OMCDs; five mice; Figure 5B) and TRPV5/ mice
(n 124 cells; nine OMCDs; four mice; Figure 5D) compared
with OMCDs exposed to 0.1 mM [Ca2] from control mice
(n  159 cells; 12 OMCDs; four mice) and TRPV5/ mice
(n  149 cells; 13 OMCDs; five mice). Comparison of pHi
recovery rates in control and TRPV5/ mouse OMCDs ex-
posed to 0.1 mM [Ca2] revealed no significant differences in
H-ATPase activity (Figure 5, B and D). To confirm the spe-
cific involvement of the H-ATPase proton pump, we per-
formed the following experiments. First, OMCDs were incu-
bated with 100 nM concanamycin, a specific H-ATPase
inhibitor, which prevented the stimulatory action of 5.0 mM
[Ca2] on the pHi recovery rate inOMCDs of control as well as
Figure 3. Immunoblotting of renal AQP2. (A) Representative immuno-
blots for AQP2, revealing 29- and 35- to 50-kD bands representing
nonglycosylated and glycosylated AQP2, respectively, which were all
included in the semiquantitative determination of renal AQP2 protein
abundance from 8-wk-old control versus TRPV5/mice (n  4). (B) Renal
AQP2 protein abundance comparing 5-wk-old control, TRPV5/,
TRPV5//Atp6v1b1/, and Atp6v1b1/ mice (n  3). (C) AQP2 ex-
pression levels in renal medullary membrane fractions from control and
TRPV5/ mice. Broad-range protein and prestained marker bands are
depicted, indicating protein size. Expression levels were corrected for
-actin expression. Data were calculated as integrated optical density
(arbitrary units), were depicted as percentage of control mice, were pre-
sented as means  SEM, and represented two separate experiments with
a total of n  4. *P  0.05 (significant difference from control); #P  0.05
(significant difference from TRPV5/).
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TRPV5/ mice. Second, the pHi recovery rates were not af-
fected by 5.0mMcomparedwith 0.1mM[Ca2] inOMCDs of
Atp6v1b1/ mice, underlining an essential role of H-
ATPase in this acidification process (Figure 5E). OMCDs from
control mice were exposed to the CaSR agonist neomycin (200
M) during the measurements to investigate the molecular
mechanism of this Ca2-mediated increase of H-ATPase ac-
tivity. Neomycin induced a significant increase in the pHi re-
covery rate (n 100 cells; eightOMCDs; fourmice) compared
with nonexposed OMCDs in the presence of 1.0 mM [Ca2]
(n 90 cells; nineOMCDs; fourmice), indicating the involve-
ment of CaSR activation (Figure 5F).
DISCUSSION
As illustrated in this study, activation of the CaSR by increased
urinary Ca2 levels triggers urinary acidification and polyuria
that are crucial adaptations in the prevention of renal stone
formation during hypercalciuria. This conclusion is based on
the following observations. First, TRPV5/mice display hy-
percalciuria as a result of impaired active Ca2 reabsorption,
concomitant hyperphosphaturia, polyuria, and increased uri-
nary acidification, whereas renal Ca2 precipitations are not
detected. Second, additional gene ablation of Atp6v1b1 in
TRPV5/ mice prevents the increased urinary acidification
and evokes massive Ca2-phosphate precipitation. Third, ac-
tivation of the renal CaSRby elevated luminal Ca2 levels stim-
ulates H-ATPase–mediated H excretion and renal AQP2
protein downregulation, responsible for the consistent in-
creased urinary acidification and polyuria, respectively, in hy-
percalciuric TRPV5/mice.
Fine-tuning of renal acid excretion is generally accom-
plished in the CD, where the H-ATPase proton pump is
localized at the apical side of type A ICs. Exposure to a 5.0
mM Ca2 concentration significantly enhanced H-
ATPase activity in OMCDs, a specific stimulatory effect that
was absent in OMCDs from Atp6v1b1/ mice. Also, the
CaSR agonist neomycin increased H-ATPase activity, em-
phasizing that CaSR activation modulates urinary acid ex-
cretion. In TRPV5/mice, an increased luminal Ca2 con-
centration is consistently present in the renal DCT, CNT,
and CD.8 This could activate the apical CaSR, increasing
H-ATPase activity and thereby initiating the observed
acidic urinary pH. Importantly, genetic ablation of TRPV5
increased NAE, which is attributed to a significant rise in
urinary TA as a result of hyperphosphaturia. In this per-
spective, the hyperphosphaturia observed in TRPV5/
mice could potentially present an acid load to the animals,
initially caused by an increase in NaPi-IIb–mediated phos-
phate absorption; however, previous investigations showed
that phosphate administration in healthy volunteers evokes
metabolic alkalosis with a concomitant increase of urinary
pH and remarkably only transient increases of TA and
NAE.26 Although a higher dietary acid load cannot be com-
pletely ruled out, it did not cause a significant change in the
acid-base homeostasis of the TRPV5/ mice. A mild met-
abolic acidosis would also have increased urinary ammo-
nium excretion, which was not observed; therefore, the de-
cline of the urinary pH in TRPV5/ mice represents a
significant renal acid loss in the presence of hyperphospha-
turia. Previously, Nijenhuis et al.27 showed that TRPV5/
mice display normal blood pH and HCO3
 levels under
basal conditions. These mice become even more alkalemic
than wild-type mice when given an NaHCO3 diet via the
drinking water, which indicates that TRPV5/mice do not
have a metabolic acidosis. Together with these observations,
our data demonstrate that TRPV5/ mice have increased
urinary acidification without an altered systemic acid-base
status.
Additional gene ablation of Atp6v1b1 in TRPV5/ mice
normalized urinary pH and caused tubular precipitation of
Ca2-phosphate in the medullary CD. These observations in-
Figure 4. Renal H-ATPase B1 subunit, NaPi-IIa co-transporter,
and NaPi-IIb co-transporter protein expression. (A) Representa-
tive immunoblots for H-ATPase B1 subunit (B1), revealing a
56-kD band in total kidney protein lysates of control and
TRPV5/mice (n 5). (B and C) Representative immunoblots for
NaPi-IIa, revealing an approximately 80-kD band in renal cortex
(n  5; B), and NaPi-IIb, revealing an approximately 80-kD band
in brush border membrane vesicles isolated from total ileum of
control and TRPV5/ mice (n  4; C). Expression levels were
normalized for -actin expression. Broad-range protein marker
bands are depicted. Data were calculated as integrated optical
density (arbitrary units), depicted as percentage of control mice,
and presented as mean  SEM. *P  0.05 (significant difference
from control).
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dicate that increased H-ATPase–mediated urinary acidifica-
tion in TRPV5/mice protects against renal Ca2-phosphate
stone formation. Because the formation of alkaline urine adds
to the risk for urinary Ca2-phosphate precipitation,28,29 renal
stones do occur in patients with distal renal tubular acidosis,
who display a urinary acidification defect and hypercalciuria.15
In accordance with our findings, previous studies demon-
strated that extracellular Ca2 levels modulate gastric acid se-
cretion, generally controlled by H-K-ATPase.11,30–33 CaSR
activation enhanced H-K-ATPase activity in iso-
lated parietal cells of gastric glands, allowing maxi-
mal ionization of dietary Ca2 and establishing en-
hanced Ca2 absorption from the intestine.30–33
Furthermore, Farajov et al.34 showed that the activa-
tion of the CaSR at the basolateral membrane of
medullary TAL cells causes increased acid secretion
in a hypercalcemic state. Together with our data, this
strongly suggests a key role of the CaSR in linking
Ca2metabolism and acid secretion.
Polyuria can diminish the risk for renal stone for-
mation by reducing the urinary Ca2 concentration.
In mice, calciuresis linearly correlated with urinary
volume, because an increase of Ca2 excretion leads
to an enhancedurinary volume. The consistent poly-
uria in hypercalciuric TRPV5/mice, assessed by a
substantial decrease in urinary osmolality, was
caused by downregulation of renal AQP2 water
channels. Specifically, immunoblot analysis revealed
a significant downregulation of AQP2 protein ex-
pression levels in isolated renal medullary mem-
brane fractions from TRPV5/ compared with
control mice. Importantly, this is in line with previ-
ous studies performed on humans and rats that sug-
gested that activation of the apical CaSR reduces the
CD water permeability when the luminal Ca2 level
rises.21,23,35 This involves the CaSR-mediated re-
trieval of AQP2 from the apical membrane into en-
docytic compartments. Recently, Bustamante et al.36
showed an attenuated AQP2 expression in a mouse
CD cell line after exposure to extracellular Ca2,
neomycin, or Gd3. Thus, hypercalciuria activates
the apical CaSR in the CD and reduces AQP2-medi-
ated water reabsorption, permitting the disposal of
excess urinary Ca2 and preventing the formation of
stones.
The B1 subunit of the renal H-ATPase proton
pump, encoded by the Atp6v1b1 gene, is impor-
tant for urinary acidification in the renal CD.37,38
Atp6v1b1/ mice demonstrated hypocalciuria,
which is an important difference in phenotype be-
tween mice and humans with a genetic Atp6v1b1
defect, although it confirms previous observations
of Finberg et al.38 The presence of hypocalciuria in
Atp6v1b1/ has not been explained yet and needs
further investigation. Moreover, Atp6v1b1/mice
displayed a higher urinary pH compared with control mice.38
Consequently, gene ablation of the Atp6v1b1 gene in
TRPV5/ mice normalized urinary pH. Interestingly,
TRPV5//Atp6v1b1/ mice evoked a more severe poly-
uria than displayed by the TRPV5/ mice. To explain the
increased urinary volume in TRPV5//Atp6v1b1/mice,
the CaSR response as a function of the extracellular pH was
previously investigated, showing the functional modulation
of the CaSR by extracellular pH.39,40 The increased urinary
Figure 5. Effect of Ca2 and neomycin on vacuolar H-ATPase activity. (A
and C) Original pHi traces from control mouse single OMCD ICs exposed to
low (0.1 mM) and high (5.0 mM) [Ca2], respectively. Bars indicate the
alternating HEPES, Na-free HEPES, and NH4Cl-containing buffers applied
to the cells. (B and D) Summary of the data from the experiments performed
in control and TRPV5/ mouse OMCD ICs, respectively. (E) ATP6v1b1/
OMCD ICs exposed to a high (5.0 mM) [Ca2]. (F) Effect of neomycin (200
M) on H-ATPase activity in control mouse OMCD ICs. (B, D, E, and F) pH
recovery rates (pH/min), which are presented as means  SEM, calculated
from number of individual OMCD ICs. *P  0.05 (significant difference from
control 0.1 mM [Ca2]); #P  0.05 (significant difference from control 5.0 mM
[Ca2]); §P 0.05 (significant difference from TRPV5/ 0.1 mM [Ca2]); ‡P
0.05 (significant difference from TRPV5/ 5.0 mM [Ca2]); $P  0.05 (sig-
nificant difference from control 1.0 mM [Ca2]). Conc, concanamycin (100
nM); Neo, neomycin.
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volume in TRPV5//Atp6v1b1/ mice compared with
TRPV5/ mice was explained by a further AQP2 down-
regulation, demonstrated by immunoblotting. We postu-
late that the extended decrease of AQP2 expression in the
TRPV5//Atp6v1b1/ mice is evoked by the higher sen-
sitivity for Ca2 of the CaSR at a neutral urinary pH. On the
basis of previous studies, we conclude that, in the absence of
increased urinary acidification in TRPV5/ mice, a more
severe reduction in water reabsorption is induced in an at-
tempt to prevent renal stone formation. Stehberger et al.41
demonstrated a decreased urinary osmolality in AE1-
deficient (AE1/) mice as a result of the retrieval of AQP2
water channels to intracellular vesicles in CD cells. This ef-
fect could be the result of increased pH sensitivity of the
CaSR at an alkaline environment. Despite the severe poly-
uria, TRPV5//Atp6v1b1/ mice developed renal Ca2-
phosphate precipitations that obstructed the CD system at
an early age. Thus, these results underscore the crucial im-
portance of increased urinary acidification in the local pre-
vention of renal Ca2-phosphate stones.
TRPV5/ mice also displayed, besides the hypercalci-
uria, a profound hyperphosphaturia, increasing the risk for
Ca2-phosphate precipitation. For maintaining normocal-
cemia, TRPV5/ mice present with a hypervitaminosis D.
Previous investigations showed that increased circulating 1,25-
dihydroxyvitamin D3 levels caused compensatory Ca
2 hy-
perabsorption by upregulation of intestinal Ca2 transport-
ers.8,42 Moreover, 1,25-dihydroxyvitamin D3 is an important
key player in phosphate homeostasis,43–45 increasing the abun-
dance of intestinal NaPi-IIb transporters.46 TRPV5/ mice
displayed a significant upregulation ofNaPi-IIb proteins in the
ileum, which might evoke phosphate hyperabsorption.
Here, we postulate that downregulation of renal NaPi-IIa
proteins results in hyperphosphaturia in TRPV5/ mice,
possibly as a compensatory response to the increased phos-
phate absorption. Whether the NaPi-IIa downregulation
could also be an effect of the hypervitaminosis D needs fur-
ther investigation.
TRPV5//Atp6v1b1/ mice exhibited growth retarda-
tion and died before 6 wk of age. The lethal phenotype is likely
to be affected by the hydronephrosis, which could be explained
by the premature formation of renal stones that physically ob-
struct the urine flow. This resembles the occurrence of hydro-
nephrosis in congenital nephropathy that is often caused by a
functional obstruction in the renal pelvis.47 Another explana-
tion could be that the hydronephrosis arises in response to the
pressure produced by the severe polyuria, dilating the CD and
leading to kidney damage. This might also clarify the individ-
ual differences in severity of the hydronephrosis, polyuria, and
early age of death observed in TRPV5//Atp6v1b1/mice.
A similar observation was previously made in the NKCC2
knockout mice, a mouse model of Bartter syndrome that dis-
played polyuria and concomitant hydronephrosis as well.48 Li
et al.49 previously investigated the presence of uremia subse-
quent to urinary tract obstruction in rats, which might have
occurred in the TRPV5//Atp6v1b1/ mice as well. The less
robust hypercalciuria observed in the TRPV5//Atp6v1b1/
mice in comparisonwith the single TRPV5/mice could be due
to the severe increase in urinary volume resulting in a slight dehy-
dration in thesemice. This could evoke increased proximal tubu-
lar Ca2 reabsorption as a compensatorymechanism, decreasing
Ca2wasting via the urine.
In conclusion, the increased urinary acidification and poly-
uria in response to hypercalciuria are prerequisites to prevent
the formation of renal Ca2-phosphate stones in TRPV5/
mice. Interestingly, these adaptations involve luminal CaSR
activation by increased urinaryCa2 levels, inducing enhanced
H-ATPase activity andAQP2 downregulation (Figure 6). Re-
nal Ca2-phosphate stone formers could benefit from the in-
duction of a decrease in urinary pH as well as polyuria that is
accomplished by increased water intake. Knowledge of these
adaptive mechanisms is relevant for the therapy and preven-
tion of kidney stones.
Figure 6. Renal CaSR signaling in the CD. The CaSR is local-
ized at the apical site of principal cells and ICs of the CD. AQP2
proteins are responsible for water reabsorption, whereas H-
ATPase proteins pump H ions into the urine. (A) In TRPV5/
mice, the CaSR is activated by increased urinary Ca2 levels.
CaSR activation leads to AQP2 downregulation, evoking poly-
uria. Furthermore, the CaSR triggers urinary acidification by
increasing the H-ATPase activity. Both polyuria and increased
urinary acidification prevent renal Ca2-phosphate precipita-
tion. (B) Genetic ablation of the Atp6v1b1 gene in the
TRPV5/ mice leads to absence of H-ATPase activity and a
decrease in urinary acidification. At a urinary pH of 7.4, Ca2-
phosphate precipitates in the CD system of TRPV5//
Atp6v1b1/ mice.
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CONCISE METHODS
Animal Experiments and Metabolic Data
Please see supplemental online information for detailed methods.
Renal Histology
Von Kossa staining of kidney tissue was performed on fixed 5- to
7-m cryosections to stain Ca2-containing deposits, and further
analysis of renal tubular Ca2 precipitations was performed by trans-
mission electron microscopy. Please see supplemental information
for detailed methods.
Protein Isolations and Immunoblotting
To quantify the renal AQP2, the H-ATPase B1 subunit, and the
NaPi-IIa protein expression levels in 8-wk-old control and
TRPV5/ mice, we prepared renal protein lysates as described be-
fore.42 Membrane fractions were isolated from renal medulla tissue,
according to centrifugation methods as described previously.50,51 For
renal AQP2 quantification in the control, TRPV5/, Atp6v1b1/,
and littermate TRPV5//Atp6v1b1/mice, kidneys were dissected
at 5 wk of age. Ileum brush bordermembrane vesicles were isolated to
quantifyNaPi-IIb protein expression levels, as described previously.43
Blots were incubated with polyclonal antibodies raised in rabbits
against AQP2, NaPi-IIa, NaPi-IIb, the B1 subunit of H-ATPase, or
the monoclonal mouse anti–-actin antibody. Please see supplemen-
tal information for detailed methods.
Tubule Preparations and pHi Measurements
Micewere transcardially perfusedwith a digestion buffer containing 1
mg/ml collagenase (Sigma-Aldrich Chemie, Buchs, Switzerland) to
obtain renal OMCDs from control, TRPV5/, and Atp6v1b1/
mice for H-ATPase activity measurements.25,31,52 BCECF AM (1
M; Molecular Probes, Invitrogen AG, Basel, Switzerland) was used
to monitor pHi. Cells were acidified using the NH4Cl (20 mM) pre-
pulse technique, as described previously.52 Please see supplemental
information for detailed methods.
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